Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare primary bone dysplasia characterized by severe developmental delay and skeletal dysplasia (including short stature, premature carpal ossification, platyspondyly, longitudinal metaphyseal striations, and small epiphyses), as well as moderate to severe intellectual disability and facial dysmorphism, including prominent forehead, mild synophrys, depressed nasal bridge, prominent bulbous nasal tip and full lips.
Features include always present findings: Short stature; and common findings: Brain shrinkage (cerebral atrophy). 48 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Seizure, Ataxia, Intellectual disability |
NANS encodes N-acetylneuraminate synthase (359 aa). Catalyzes the condensation of phosphoenolpyruvate (PEP) and N-acetylmannosamine 6-phosphate (ManNAc-6-P) to synthesize N-acetylneuraminate-9-phosphate (Neu5Ac-9-P). Highest expression in Prostate (35.8 TPM) and Colon Transverse (31.5 TPM).
Spondyloepimetaphyseal dysplasia, Genevieve type is caused by mutations in the NANS gene on chromosome 9.
The NANS protein participates in NANS converts ManNAc-6-P to Neu5Ac-9-P pathway.
NANS is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for NANS is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spondyloepimetaphyseal dysplasia, Genevieve type.
1 publication has been identified in PubMed for spondyloepimetaphyseal dysplasia, Genevieve type. Research spans Review / Meta-Analysis (100%).
Koles K (2026). [PMID: 41708000](https://pubmed.ncbi.nlm.nih.gov/41708000/). *The Journal of biological chemistry*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 1:53 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
6 |
Carpal bone hypoplasia, Joint hypermobility, Short femoral neck |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Brain shrinkage (cerebral atrophy) |
Head and neck | 3 | Coarse facial features, Microcephaly, Thick lower lip vermilion |
Eyes | 2 | Strabismus, Nystagmus |
Growth and development | 1 | Short stature |